Chen C - Search Results

1

Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901: interim results of a large-scale, double-blind, randomised, placebo-controlled phase 2 trial in Taiwan.

Hsieh SM, Liu MC, Chen YH, Lee WS, Hwang SJ, Cheng SH, Ko WC, Hwang KP, Wang NC, Lee YL, Lin YL, Shih SR, Huang CG, Liao CC, Liang JJ, Chang CS, Chen C, Lien CE, Tai IC, Lin TY. Hsieh SM, et al. Among authors: chen yh, chen c. Lancet Respir Med. 2021 Dec;9(12):1396-1406. doi: 10.1016/S2213-2600(21)00402-1. Epub 2021 Oct 13. Lancet Respir Med. 2021. PMID: 34655522 Free PMC article. Clinical Trial.

2

The safety and immunogenicity of a cell-derived adjuvanted H5N1 vaccine - A phase I randomized clinical trial.

Cheng A, Hsieh SM, Pan SC, Li YH, Hsieh EF, Lee HC, Lin TW, Lai KL, Chen C, Shi-Chung Chang S, Chang SC. Cheng A, et al. Among authors: chen c. J Microbiol Immunol Infect. 2019 Oct;52(5):685-692. doi: 10.1016/j.jmii.2019.03.009. Epub 2019 May 18. J Microbiol Immunol Infect. 2019. PMID: 31255574 Free article. Clinical Trial.

3

Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19.

Kuo TY, Lin MY, Coffman RL, Campbell JD, Traquina P, Lin YJ, Liu LT, Cheng J, Wu YC, Wu CC, Tang WH, Huang CG, Tsao KC, Chen C. Kuo TY, et al. Among authors: chen c. Sci Rep. 2020 Nov 18;10(1):20085. doi: 10.1038/s41598-020-77077-z. Sci Rep. 2020. PMID: 33208827 Free PMC article.

4

CpG-adjuvanted stable prefusion SARS-CoV-2 spike protein protected hamsters from SARS-CoV-2 challenge.

Lien CE, Lin YJ, Chen C, Lian WC, Kuo TY, Campbell JD, Traquina P, Lin MY, Liu LT, Chuang YS, Ko HY, Liao CC, Chen YH, Jan JT, Ma HH, Sun CP, Lin YS, Wu PY, Wang YC, Tao MH, Lin YL. Lien CE, et al. Among authors: chen yh, chen c. Sci Rep. 2021 Apr 22;11(1):8761. doi: 10.1038/s41598-021-88283-8. Sci Rep. 2021. PMID: 33888840 Free PMC article.

5

Safety and immunogenicity of a Recombinant Stabilized Prefusion SARS-CoV-2 Spike Protein Vaccine (MVC-COV1901) Adjuvanted with CpG 1018 and Aluminum Hydroxide in healthy adults: A Phase 1, dose-escalation study.

Hsieh SM, Liu WD, Huang YS, Lin YJ, Hsieh EF, Lian WC, Chen C, Janssen R, Shih SR, Huang CG, Tai IC, Chang SC. Hsieh SM, et al. Among authors: chen c. EClinicalMedicine. 2021 Aug;38:100989. doi: 10.1016/j.eclinm.2021.100989. Epub 2021 Jun 26. EClinicalMedicine. 2021. PMID: 34222848 Free PMC article.

6

Evaluating the Neutralizing Ability of a CpG-Adjuvanted S-2P Subunit Vaccine Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern.

Lien CE, Kuo TY, Lin YJ, Lian WC, Lin MY, Liu LT, Cheng J, Chou YC, Chen C. Lien CE, et al. Among authors: chen c. Clin Infect Dis. 2022 Jun 10;74(11):1899-1905. doi: 10.1093/cid/ciab711. Clin Infect Dis. 2022. PMID: 34739037 Free PMC article.

7

Structures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2.

Huang KA, Zhou D, Tan TK, Chen C, Duyvesteyn HME, Zhao Y, Ginn HM, Qin L, Rijal P, Schimanski L, Donat R, Harding A, Gilbert-Jaramillo J, James W, Tree JA, Buttigieg K, Carroll M, Charlton S, Lien CE, Lin MY, Chen CP, Cheng SH, Chen X, Lin TY, Fry EE, Ren J, Ma C, Townsend AR, Stuart DI. Huang KA, et al. Among authors: chen c, chen cp, chen x. Theranostics. 2022 Jan 1;12(1):1-17. doi: 10.7150/thno.65563. eCollection 2022. Theranostics. 2022. PMID: 34987630 Free PMC article.

8

Efficacy, safety, and immunogenicity of an inactivated, adjuvanted enterovirus 71 vaccine in infants and children: a multiregion, double-blind, randomised, placebo-controlled, phase 3 trial.

Nguyen TT, Chiu CH, Lin CY, Chiu NC, Chen PY, Le TTV, Le DN, Duong AH, Nguyen VL, Huynh TN, Truong HK, Phan TL, Nguyen TTT, Shih SR, Huang CG, Weng YJ, Hsieh EF, Chang S, Chen C, Tai IC, Huang LM. Nguyen TT, et al. Among authors: chen py, chen c. Lancet. 2022 Apr 30;399(10336):1708-1717. doi: 10.1016/S0140-6736(22)00313-0. Epub 2022 Apr 12. Lancet. 2022. PMID: 35427481 Clinical Trial.

9

Hamsters Protected from SARS-CoV-2 Delta Variant Challenge after Two Doses of Adjuvanted SARS-CoV-2 Recombinant Spike Protein (S-2P) and One Dose of Beta S-2P.

Kuo TY, Lien CE, Lin YJ, Lin MY, Wu CC, Tang WH, Campbell JD, Traquina P, Chuang YS, Liu LT, Cheng J, Chen C. Kuo TY, et al. Among authors: chen c. J Infect Dis. 2022 Nov 1;226(9):1562-1567. doi: 10.1093/infdis/jiac153. J Infect Dis. 2022. PMID: 35451470 Free PMC article.

10

Protection of hamsters challenged with SARS-CoV-2 after two doses of MVC-COV1901 vaccine followed by a single intranasal booster with nanoemulsion adjuvanted S-2P vaccine.

Lin YJ, Lin MY, Chuang YS, Liu LT, Kuo TY, Chen C, Ganesan S, Fattom A, Bitko V, Lien CE. Lin YJ, et al. Among authors: chen c. Sci Rep. 2022 Jul 5;12(1):11369. doi: 10.1038/s41598-022-15238-y. Sci Rep. 2022. PMID: 35790783 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90,617 results

Search Page

Filters